Replies to post #230995 on Biotech Values

[DewDiligence]

ABT 1Q20 sales by business segment:

  
 Medical devices* 38% (+3% YoY in const currency) 
 Nutrition        25% (+7% YoY in const currency) 
 Diagnostics      24% (+1% YoY in const currency) 
 Drugs†           14% (+9% YoY in const currency)

63% of overall sales were ex-US.

*Including diabetes care.
†Branded generics in emerging markets.